Under construction – not a live service
Sign in
Not yet taking people in LithuaniaNo phase

Smart Technologies in Early Post-Stroke Rehabilitation

Key facts

Where
Kaunas, LithuaniaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT07171073, who can take part

Where in Lithuania

  • Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Neurorehabilitation DepartmentKaunas, LithuaniaNo longer taking part
  • Lithuanian University of Health Sciences, Hospital Kaunas Clinics, Kulautuva Rehabilitation HospitalKaunas, LithuaniaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Erika Endzelyte
Trial code
NCT07171073
Record updated
12 September 2025
Original description
The goal of this interventional study is to evaluate the impact of applying different smart technologies during early rehabilitation after stroke. The primary hypothesis is that the use of smart technologies in the early stage of rehabilitation will significantly improve biosocial and cognitive functions, quality of life, and participation in activities. Furthermore, the extent of these improvements may differ depending on the type of technology used and individual patient characteristics.Read full original descriptionShow less

Changes in Biosocial and Cognitive Functions and Quality of Life When Applying Different Smart Technologies in Stroke Patients During Early Rehabilitation

The goal of this interventional study is to evaluate the impact of applying different smart technologies during early rehabilitation after stroke. The primary hypothesis is that the use of smart technologies in the early stage of rehabilitation will significantly improve biosocial and cognitive functions, quality of life, and participation in activities. Furthermore, the extent of these improvements may differ depending on the type of technology used and individual patient characteristics.

The specific aims of the study are:

* To evaluate changes in biosocial and cognitive functions in stroke patients using different smart technologies during early rehabilitation. * To assess changes in quality of life and participation in daily activities. * To compare the effectiveness of different smart technologies on recovery outcomes. * To identify patient-specific factors influencing rehabilitation results. A total of four groups will be studied. Three experimental groups will receive interventions with different interactive rehabilitation technologies (RecoveriX, Gloreha Aria, E-Link). The control group will undergo standard occupational therapy. All groups will receive the same level of conventional rehabilitation and medical care.

Assessments will be conducted at the beginning and end of the 6-7 week rehabilitation program, covering motor, cognitive, and biosocial functioning, as well as quality of life.

The results are expected to provide new knowledge on the effectiveness of smart technologies in stroke rehabilitation, to guide the development of personalized rehabilitation programs, and to support evidence-based decisions for occupational therapy and health care practice.

Inclusion: Signed informed consent; Ischemic stroke confirmed by imaging (CT or MRI); Hemiplegia/hemiparesis with arm motor deficit (muscle strength ≤ 4 points on Lovett scale); Time since stroke ≤ 1 month; No severe cognitive impairment (MMSE ≥ 18); Native Lithuanian speaker.

Exclusion: Previous craniotomy or severe head trauma with loss of consciousness; Previous significant arm function deficits unrelated to stroke; Contraindications for RecoveriX (metallic implants in the head, cochlear implants, cardiac pacemaker); Epilepsy or history of seizures; Severe aphasia or severe comprehension impairment (MMSE < 18); Unilateral neglect syndrome (Hemispatial neglect); Declines participation; Severe comorbidities affecting biosocial functions; Severe visual or hearing impairments interfering with participation.

ClinicalTrials.gov NCT07171073